LongCovid
New article in The Lancet aimed to study the effectiveness of one-dose of intranasal spray COVID-19 vaccine (dNS1-RBD) against symptomatic Omicron infections in real-world conditions. This prospective cohort study was…
Health-NCP-Net 3.0 (HNN 3.0) is a European project that is aimed at aligning and enhancing the services that National Contact Points (NCPs) for Cluster “Health” (CL1) provide to…
At the 2023 Burnet Oration, COVID-19 researcher Dr. Ziyad Al-Aly, chief of research and development at VA Saint Louis Health Care System and senior clinical epidemiologist for the Institute…
On the 4th of December, German Health Minister Karl Lauterbach provided a crucial and very valuable update on the ongoing Long COVID situation in Germany. “We have to remain cautious: Long…
Do not miss this very interesting talk of Dr. Giuseppe Balistreri, PhD (WP2 leader in Long COVID project) at the Australian Neuroscience Society 41st Annual Scientific Meeting. He will present…
A study led by the University of Leeds has recently been posted to The Lancet, where researchers followed up individuals with Long COVID, throughout a longitudinal study. “This is the first study…
The second issue of the Long COVID newsletter is out now! – Do you want to know about the cohort and clinical studies carried out in Finland so far and…
Very relevant scientific article published in the Journal of Translational Medicine presenting the list of genes significantly associated with Long COVID. “Combinatorial analysis identified 73 genes that were highly associated…
New Scientific Reports article on Post-acute COVID-19 (PACS) and its association with cardiovascular dysfunction, especially postural orthostatic tachycardia syndrome (POTS). “The aim of this study was to provide…
Federal Minister of Health Prof. Dr. Karl Lauterbach just announced 150 million euros for Long Covid research in Germany for the coming years. According to Lauterbach, in addition to 100…